Roche launches Emicizumab in India

Drug Discovery |  News | 0 Comment | 21 Apr, 2019

Roche has declared  that Emicizumab (Hemlibra®) has been approved in India for Hemophilia A with factor VIII in...Read more

Japan grants Sakigake designation to Eisai’s novel FGFR

Drug Discovery |  News | 0 Comment | 08 Apr, 2019

Eisai Co., Ltd. is a leading global research and development-based pharmaceutical company headquartered in Japan. The co...Read more

Takeda takes step towards EU Entyvio extension

Drug Discovery |  News | 0 Comment | 02 Apr, 2019

Takeda Pharmaceutical Company Limited announced that the European Medicines Agency (EMA) has accepted a Marketing Author...Read more

Standigm raises $11.5M in Series B Round

Drug Discovery |  News | 0 Comment | 02 Apr, 2019

Standigm, a company using artificial intelligence (AI) technology for drug discovery and development, announced it has r...Read more

Takeda, StrideBio to advance novel gene therapies for neuro diseases

Drug Discovery |  News | 0 Comment | 01 Apr, 2019

StrideBio, Inc, a leading developer of novel adeno-associated viral (AAV) based gene therapies, recently announced the s...Read more

HitGen, Almirall to identify novel drug targets

Drug Discovery |  News | 0 Comment | 26 Mar, 2019

HitGen has announced that the company has entered into a research collaboration with Almirall to identify novel small mo...Read more

BioInvent developes Anti-TNFR2 programme for cancer treatment

Drug Discovery |  News | 0 Comment | 21 Mar, 2019

BioInvent International AB, focused on the discovery and development of novel and first-in-class immuno-regulatory antib...Read more

EC approves Roche’s MabThera for a rare autoimmune disease

Drug Discovery |  News | 0 Comment | 19 Mar, 2019

Roche announced that the European Commission has approved MabThera® (rituximab) for the treatment of adults with mod...Read more

Ono Pharma, twoXAR announce drug discovery research collaboration

Drug Discovery |  News | 0 Comment | 19 Mar, 2019

Ono Pharmaceutical Co., Ltd., a Japanese pharmaceutical research and development company, and twoXAR, Inc., a US based a...Read more

Janssen seeks USFDA nod for Darzalex to treat ASCT multiple myeloma

Drug Discovery |  News | 0 Comment | 14 Mar, 2019

The Janssen Pharmaceutical Companies of Johnson & Johnson announced the submission of a supplemental Biologics Licen...Read more

FDA approves new nasal spray for treatment-resistant depression

Drug Discovery |  News | 0 Comment | 06 Mar, 2019

The U.S. Food and Drug Administration has approved Spravato (esketamine) nasal spray, in conjunction with an oral antide...Read more

Glenmark announces presentation of New Subtype Analysis of GBR 830

Drug Discovery |  News | 0 Comment | 04 Mar, 2019

Glenmark Pharmaceuticals has announced the presentation of a new post hoc analysis of data from a Phase 2a, proof-of-con...Read more

USFDA accepts Merck and Pfizer’s sBLA for Renal Cancer drug

Drug Discovery |  News | 0 Comment | 12 Feb, 2019

Merck and Pfizer Inc. has announced that the US Food and Drug Administration (FDA) has accepted for Priority Review...Read more

Teva announces US launch of Vigabatrin

Drug Discovery |  News | 0 Comment | 08 Feb, 2019

Teva Pharmaceutical Industries has announced the launch of a generic version of Sabril®1 (vigabatrin) tablets, ...Read more

Perrigo to launch its AB rated generic Zovirax cream

Drug Discovery |  News | 0 Comment | 07 Feb, 2019

Perrigo Company plc has announced it has received final approval from the U.S. Food and Drug Administration for its AB r...Read more

BioLineRx gets Orphan Drug Designation for its pancreatic cancer drug

Drug Discovery |  News | 0 Comment | 07 Feb, 2019

BioLineRx Ltd., an Israeli clinical-stage biopharmaceutical company focused on oncology, announced that the U.S. Food an...Read more

Reaction Biology Corporation buys ProQinase GmbH

Drug Discovery |  News | 1 Comment | 05 Feb, 2019

Reaction Biology Corporation ("RBC") and ChinaEquity Group ("CEG") have announced the conclusion of a stock exchange tra...Read more

I-Mab, BCT to work on Arginine Depletion Therapy and Biomarker Study

Drug Discovery |  News | 0 Comment | 04 Feb, 2019

I-Mab Biopharma (I-Mab), a China-based clinical stage biopharmaceutical company exclusively focused on the developm...Read more